Nektar Therapeutics Falls Victim To The Index Curse
August 09, 2019 at 14:48 PM EDT
The last year and a half has been tough for NKTR, what’s even worse is that all of the problems for the stock started to happen right when it was added to the S&P 500 in March 2018.
